edoc

Items where Division is "03 Faculty of Medicine > Bereich Medizinische Fächer (Klinik) > Onkologie"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Creators | Refereed
Jump to: 2012 | 2011 | 2010 | 2009 | 2008 | 2006
Number of items at this level: 71.

2012

Chirgwin, Jacquie and Sun, Zhuoxin and Smith, Ian and Price, Karen N. and Thürlimann, Beat and Ejlertsen, Bent and Bonnefoi, Hervé and Regan, Meredith M. and Goldhirsch, Aron and Coates, Alan S. and International Breast Cancer Study Groups, . (2012) The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause. Breast cancer research and treatment, Vol. 131, H. 1. S. 295-306.

2011

Bolla, Daniele and Ruhstaller, Thomas and Diener, Pierre-André and Lang, Franziska and Hornung, Rène. (2011) Cervical and vaginal cancer in a woman with chronic graft-versus-host disease. International journal of gynecology & obstetrics, Vol. 114, H. 2. S. 159-160.

Bolla, Daniele and Wiedemann, Nicole and Ohlschlegel, Christin and Schöning, Andrea and Stickel, Juliane and Thürlimann, Beat and Hornung, René. (2011) Pseudoangiomatous stromal hyperplasia of breast in man: a case report. The breast journal, Vol. 17, H. 3. S. 311-312.

Colleoni, Marco and Giobbie-Hurder, Anita and Regan, Meredith M. and Thürlimann, Beat and Mouridsen, Henning and Mauriac, Louis and Forbes, John F. and Paridaens, Robert and Láng, István and Smith, Ian and Chirgwin, Jacquie and Pienkowski, Tadeusz and Wardley, Andrew and Price, Karen N. and Gelber, Richard D. and Coates, Alan S. and Goldhirsch, Aron. (2011) Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study. Journal of clinical oncology, Vol. 29, H. 9. S. 1117-1124.

Ess, S. and Joerger, M. and Frick, H. and Probst-Hensch, N. and Vlastos, G. and Rageth, C. and Lütolf, U. and Savidan, A. and Thürlimann, B.. (2011) Predictors of state-of-the-art management of early breast cancer in Switzerland. Annals of oncology, Vol. 22, H. 3. S. 618-624.

Goldhirsch, A. and Wood, W. C. and Coates, A. S. and Gelber, R. D. and Thürlimann, B. and Senn, H.-J. and Panel members, . (2011) Strategies for subtypes-dealing with the diversity of breast cancer : highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Annals of oncology, Vol. 22, H. 8. S. 1736-1747.

Huober, Jens and Baumann, Michael and Rochlitz, Christoph and Aebi, Stefan and Güth, Uwe and von Moos, Roger and Müller, Andreas and von Rohr, Lukas and Widmer, Isabelle and Thürlimann, Beat. (2011) Trastuzumab treatment beyond progression in advanced breast cancer : patterns of care in six Swiss breast cancer centers. Oncology, Vol. 81, H. 3-4. S. 160-166.

Joerger, M. and Riesen, W. F. and Thürlimann, B.. (2011) Bevacizumab-associated hyperlipoproteinemia type IIb in a patient with advanced invasive-ductal breast cancer. Journal of oncology pharmacy practice, Vol. 17, H. 3. S. 292-294.

Joerger, M. and Templeton, A. and Köberle, D. and Engler, H. and Riesen, W. F. and Thürlimann, B.. (2011) Procollagen type I N-propeptide is a predictor of skeletal morbidity in patients with malignant osteolytic bone disease on bisphosphonates. Cancer chemotherapy and pharmacology, Vol. 67, H. 5. S. 1137-1144.

Joerger, M. and Thürlimann, B. and Huober, J.. (2011) Small HER2-positive, node-negative breast cancer : who should receive systemic adjuvant treatment? Annals of oncology, Vol. 22. S. 17-23.

Koeberle, D. and Ruhstaller, T. and Jost, L. and Pagani, O. and Zaman, K. and von Moos, R. and Oehlschlegel, C. and Crowe, S. and Pilop, C. and Thuerlimann, B. and Swiss Grp Clinical Canc Res Sakk, . (2011) Combination of trastuzumab and letrozole after resistance to sequential trastuzumab and aromatase inhibitor monotherapies in patients with estrogen receptor-positive, HER-2-positive advanced breast cancer : a proof-of-concept trial (SAKK 23/03). Endocrine related cancer, Vol. 18, H. 2. S. 257-264.

Phillips, Kelly-Anne and Aldridge, Julie and Ribi, Karin and Sun, Zhuoxin and Thompson, Alastair and Harvey, Vernon and Thürlimann, Beat and Cardoso, Fatima and Pagani, Olivia and Coates, Alan S. and Goldhirsch, Aron and Price, Karen N. and Gelber, Richard D. and Bernhard, Jürg. (2011) Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial. Breast cancer research and treatment, Vol. 126, H. 1. S. 221-226.

Regan, Meredith M. and Neven, Patrick and Giobbie-Hurder, Anita and Goldhirsch, Aron and Ejlertsen, Bent and Mauriac, Louis and Forbes, John F. and Smith, Ian and Láng, István and Wardley, Andrew and Rabaglio, Manuela and Price, Karen N. and Gelber, Richard D. and Coates, Alan S. and Thürlimann, Beat and International Breast Cancer Study Group, . (2011) Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer : the BIG 1-98 randomised clinical trial at 8·1 years median follow-up. The Lancet oncology, Vol. 12, H. 12. S. 1101-1108.

Regan, Meredith M. and Price, Karen N. and Giobbie-Hurder, Anita and Thürlimann, Beat and Gelber, Richard D. and International Breast Cancer Study Group, . (2011) Interpreting Breast International Group (BIG) 1-98 : a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer. Breast cancer research, Vol. 13, H. 3. S. 209.

Rochlitz, C. and Ruhstaller, T. and Lerch, S. and Spirig, C. and Huober, J. and Suter, T. and Buhlmann, M. and Fehr, M. and Schonenberger, A. and von Moos, R. and Winterhalder, R. and Rauch, D. and Muller, A. and Mannhart-Harms, M. and Herrmann, R. and Cliffe, B. and Mayer, M. and Zaman, K.. (2011) Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer : a multicenter, single-arm phase II trial (SAKK 24/06). Annals of oncology, Vol. 22, H. 1. S. 80-85.

Ruhstaller, Thomas and Pless, Miklos and Dietrich, Daniel and Kranzbuehler, Helmut and von Moos, Roger and Moosmann, Peter and Montemurro, Michael and Schneider, Paul M. and Rauch, Daniel and Gautschi, Oliver and Mingrone, Walter and Widmer, Lucas and Inauen, Roman and Brauchli, Peter and Hess, Viviane. (2011) Cetuximab in Combination With Chemoradiotherapy Before Surgery in Patients With Resectable, Locally Advanced Esophageal Carcinoma : a Prospective, Multicenter Phase IB/II Trial (SAKK 75/06). Journal of clinical oncology, Vol. 29, H. 6. S. 626-631.

Viale, G. and Regan, M. M. and Dell'Orto, P. and Mastropasqua, M. G. and Maiorano, E. and Rasmussen, B. B. and MacGrogan, G. and Forbes, J. F. and Paridaens, R. J. and Colleoni, M. and Láng, I. and Thürlimann, B. and Mouridsen, H. and Mauriac, L. and Gelber, R. D. and Price, K. N. and Goldhirsch, A. and Gusterson, B. A. and Coates, A. S. and International Breast Cancer Study Groups, . (2011) Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial. Annals of oncology, Vol. 22, H. 10. S. 2201-2207.

2010

Antonov, Janine and Popovici, Vlad and Delorenzi, Mauro and Wirapati, Pratyaksha and Baltzer, Anna and Oberli, Andrea and Thürlimann, Beat and Giobbie-Hurder, Anita and Viale, Giuseppe and Altermatt, Hans Jörg and Aebi, Stefan and Jaggi, Rolf. (2010) Molecular risk assessment of BIG 1-98 participants by expression profiling using RNA from archival tissue. BMC cancer, Vol. 10 , 37. S. 37.

Brauchli, Peter and Thürlimann, Beat and Crowe, Susanne N. and Herrmann, Richard. (2010) What is the value of the 21-gene recurrence score? Journal of clinical oncology, Vol. 28 , e671-e672.

Ess, S. and Savidan, A. and Frick, H. and Rageth, Ch and Vlastos, G. and Lütolf, U. and Thürlimann, B.. (2010) Geographic variation in breast cancer care in Switzerland. Cancer epidemiology, Vol. 34, H. 2. S. 116-121.

Hawle, H. and Hess, D. and Mueller, A. and Thuerlimann, B.. (2010) Low-Dose Fulvestrant Maintained Long-Term Complete Remission after Poor Response to Previous Endocrine Therapies in a Patient with Advanced Breast Cancer. Case reports in oncology, Vol. 3, H. 2. S. 131-136.

Huober, Jens and Schoch, Otto and Templeton, Arnoud and Spirig, Christian and Thürlimann, Beat. (2010) Interstitial pneumonitis after treatment with bevacizumab and pegylated liposomal doxorubicin in a patient with metastatic breast cancer. Chemotherapy, Vol. 56, H. 1. S. 69-70.

Huober, Jens and Thürlimann, Beat. (2010) Bone targeted therapy in breast cancer : present and future. Critical reviews in oncology, hematology, Vol. 74, Suppl. 1 , S7-10.

Mouridsen, Henning T. and Lønning, Per and Beckmann, Matthias W. and Blackwell, Kimberly and Doughty, Julie and Gligorov, Joseph and Llombart-Cussac, Antonio and Robidoux, Andre and Thürlimann, Beat and Gnant, Michael. (2010) Use of aromatase inhibitors and bisphosphonates as an anticancer therapy in postmenopausal breast cancer. Expert review of anticancer therapy, Vol. 10, H. 11. S. 1825-1836.

Paridaens, Robert J. and Gelber, Shari and Cole, Bernard F. and Gelber, Richard D. and Thürlimann, Beat and Price, Karen N. and Holmberg, Stig B. and Crivellari, Diana and Coates, Alan S. and Goldhirsch, Aron. (2010) Adjuvant! Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer. Breast cancer research and treatment, Vol. 123, H. 1. S. 303-310.

Phillips, Kelly-Anne and Ribi, Karin and Sun, Zhuoxin and Stephens, Alisa and Thompson, Alastair and Harvey, Vernon and Thürlimann, Beat and Cardoso, Fatima and Pagani, Olivia and Coates, Alan S. and Goldhirsch, Aron and Price, Karen N. and Gelber, Richard D. and Bernhard, Jürg. (2010) Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial. The breast, Vol. 19, H. 5. S. 388-395.

Scientific Board, and Harbeck, Nadia and von Minckwitz, Gunter and Thürlimann, Beat. (2010) Bisphosphonates in adjuvant treatment of early breast cancer. Critical reviews in oncology, hematology, Vol. 74 , S1.

Thürlimann, Beat. (2010) [Commentary from the viewpoint of an advocate. "Breast cancer mortality in organized mammography screening in Denmark: a comparative Study"]. Schweizerische Rundschau für Medizin PRAXIS, Vol. 99, H. 20. S. 1217-1218.

von Moos, Roger and Caspar, Clemens B. and Steiner, Rolf and Angst, Rahel and Inauen, Roman and Schmieding, Kerstin and Thürlimann, Beat. (2010) Long-term renal safety profile of ibandronate 6 mg infused over 15 minutes. Onkologie, Vol. 33, H. 8-9. S. 447-450.

2009

Biganzoli, Laura and Bonnefoi, Hervé and Cardoso, Fatima and Coleman, Robert and Thürlimann, Beat. (2009) ASCO 2009: What's New in Breast Cancer Therapy? Breast care, Vol. 4, No. 4. S. 268-271.

Colleoni, M. and Sun, Z. and Martinelli, G. and Basser, R. L. and Coates, A. S. and Gelber, R. D. and Green, M. D. and Peccatori, F. and Cinieri, S. and Aebi, S. and Viale, G. and Price, K. N. and Goldhirsch, A. and International, Breast Cancer Study Group. (2009) The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up. Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 8. S. 1344-1351.

Giobbie-Hurder, A. and Price, K. N. and Gelber, R. D. and International, Breast Cancer Study Group. (2009) Design, conduct, and analyses of Breast International Group (BIG) 1-98 : a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer. Clinical trials : journal of the Society for Clinical Trials, Vol. 3. S. 272-287.

Goldhirsch, A. and Ingle, J. N. and Gelber, R. D. and Coates, A. S. and Thürlimann, B. and Senn, H.-J.. (2009) Thresholds for therapies : highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 20. S. 1319-1329.

Huober, J. and Thürlimann, B.. (2009) Adjuvant! When the new world meets the old world. The Lancet oncology, Vol. 10, H. 11. S. 1028-1029.

Huober, Jens and Thürlimann, Beat. (2009) The Role of Combination Chemotherapy in the Treatment of Patients with Metastatic Breast Cancer. Breast care, Vol. 4. S. 367-372.

Jakesz, R. and Dubsky, P. and Eidtman, H. and Schem, C. and Lang, A. and Thürlimann, B.. (2009) Neue Erkenntnisse vom SABCS Expert Discussion. Breast care : multidisciplinary journal for research, diagnosis and therapy, Vol. 4, No. 1. S. 55-60.

Joerger, Markus and Thürlimann, Beat. (2009) Update of the BIG 1-98 Trial : where do we stand? The breast : official journal of the European Society of Mastology, Vol. 18 , S78-82.

Jörger, M. and J. Senn, H. and Thürlimann, B.. (2009) St.Gallen 2009 recommendations on the treatment of early breast cancer : consensus and controversy. Magazine of European Medical Oncology : MEMO; official journal of the Central European Cooperative Oncology Group (CECOG), Vol. 2, H. 4. S. 229-231.

Klaeser, Bernd and Nitzsche, Egbert and Schuller, Jan C. and Köberle, Dieter and Widmer, Lucas and Balmer-Majno, Sabine and Hany, Thomas and Cescato-Wenger, Corinne and Brauchli, Peter and Zünd, Michael and Pestalozzi, Bernhard C. and Caspar, Clemens and Albrecht, Susanne and von Moos, Roger and Ruhstaller, Thomas. (2009) Limited predictive value of FDG-PET for response assessment in the preoperative treatment of esophageal cancer : results of a prospective multi-center trial (SAKK 75/02). Onkologie : Zeitschrift für Krebsforschung und -behandlung, Vol. 32. S. 724-730.

Mouridsen, Henning and Giobbie-Hurder, Anita and Goldhirsch, Aron and Thürlimann, Beat and Paridaens, Robert and Smith, Ian and Mauriac, Louis and Forbes, John F. and Price, Karen N. and Regan, Meredith M. and Gelber, Richard D. and Coates, Alan S.. (2009) Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer. The New England journal of medicine, Vol. 361. S. 766-776.

Pagani, Olivia and Gelber, Shari and Simoncini, Edda and Castiglione-Gertsch, Monica and Price, Karen N. and Gelber, Richard D. and Holmberg, Stig B. and Crivellari, Diana and Collins, John and Lindtner, Jurij and Thürlimann, Beat and Fey, Martin F. and Murray, Elizabeth and Forbes, John F. and Coates, Alan S. and Goldhirsch, Aron. (2009) Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93. Breast cancer research and treatment, Vol. 116. S. 491-500.

Pagani, Olivia and Price, Karen N. and Gelber, Richard D. and Castiglione-Gertsch, Monica and Holmberg, Stig B. and Lindtner, Jurij and Thürlimann, Beat and Collins, John and Fey, Martin F. and Coates, Alan S. and Goldhirsch, Aron. (2009) Patterns of recurrence of early breast cancer according to estrogen receptor status : a therapeutic target for a quarter of a century. Breast cancer research and treatment, Vol. 117. S. 319-324.

Rabaglio, M. and Sun, Z. and Price, K. N. and Castiglione-Gertsch, M. and Hawle, H. and Thürlimann, B. and Mouridsen, H. and Campone, M. and Forbes, J. F. and Paridaens, R. J. and Colleoni, M. and Pienkowski, T. and Nogaret, J.-M. and Láng, I. and Smith, I. and Gelber, R. D. and Goldhirsch, A. and Coates, A. S.. (2009) Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial. Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 20. S. 1489-1498.

Ruhstaller, T. and Widmer, L. and Schuller, J. C. and Roth, A. and Hess, V. and Mingrone, W. and von Moos, R. and Borner, M. and Pestalozzi, B. C. and Balmermajno, S. and Köberle, D. and Terraciano, L. and Schnider, A. and Bodis, S. and Popescu, R.. (2009) Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02). Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 20. S. 1522-1528.

Ruhstaller, Thomas and von Moos, Roger and Rufibach, Kaspar and Ribi, Karin and Glaus, Agnes and Spaeti, Bruno and Koeberle, Dieter and Mueller, Urs and Hoefliger, Markus and Hess, Dagmar and Boehme, Christel and Thuerlimann, Beat. (2009) Breast cancer patients on endocrine therapy reveal more symptoms when self-reporting than in pivotal trials: an outcome research study. Oncology : international journal of cancer research and treatment, Vol. 76. S. 142-148.

Spirig, Christian and Omlin, Aurelius and D'Addario, Giannicola and Loske, Klaus-Dieter and Esenwein, Philipp and Geismar, Jan Henning and Ruhstaller, Thomas. (2009) Radiation recall dermatitis with soft tissue necrosis following pemetrexed therapy : a case report. Journal of medical case reports, Vol. 3. S. 93.

Templeton, A. and Thürlimann, B. and Jörger, M.. (2009) Ixabepilon bei lokal fortgeschrittenem oder metastasiertem Mammakarzinom: Neue Behandlungsoptionen nach Taxanen und Anthrazyklinen. Schweizer Krebsbulletin, 2009, Nr. 2. S. 114-117.

Thürlimann, Beat and Price, Karen N. and Gelber, Richard D. and Holmberg, Stig B. and Crivellari, Diana and Colleoni, Marco and Collins, John and Forbes, John F. and Castiglione-Gertsch, Monica and Coates, Alan S. and Goldhirsch, Aron. (2009) Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93. Breast cancer research and treatment, Vol. 113. S. 137-144.

2008

Aapro, M. and Abrahamsson, P. A. and Body, J. J. and Coleman, R. E. and Colomer, R. and Costa, L. and Crinò, L. and Dirix, L. and Gnant, M. and Gralow, J. and Hadji, P. and Hortobagyi, G. N. and Jonat, W. and Lipton, A. and Monnier, A. and Paterson, A. H. G. and Rizzoli, R. and Saad, F. and Thürlimann, B.. (2008) Guidance on the use of bisphosphonates in solid tumours : recommendations of an international expert panel. Annals of oncology, Vol. 19, H. 3. S. 420-432.

Bernhard, J. and Dietrich, D. and Scheithauer, W. and Gerber, D. and Bodoky, G. and Ruhstaller, T. and Glimelius, B. and Bajetta, E. and Schüller, J. and Saletti, P. and Bauer, J. and Figer, A. and Pestalozzi, B. C. and Köhne, C. H. and Mingrone, W. and Stemmer, S. M. and Tàmas, K. and Kornek, G. V. and Koeberle, D. and Herrmann, R. and Central, European Cooperative Oncology Group. (2008) Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone : a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001. Journal of clinical oncology, Vol. 26. S. 3695-3701.

Bernhard, J. and Zahrieh, D. and Zhang, J. J. and Martinelli, G. and Basser, R. and Hürny, C. and Forbes, J. F. and Aebi, S. and Yeo, W. and Thürlimann, B. and Green, M. D. and Colleoni, M. and Gelber, R. D. and Castiglione-Gertsch, M. and Price, K. N. and Goldhirsch, A. and Coates, A. S.. (2008) Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer. British journal of cancer, Vol. 98, no. 1. S. 25-33.

Borner, M. and Koeberle, D. and Von Moos, R. and Saletti, P. and Rauch, D. and Hess, V. and Trojan, A. and Helbling, D. and Pestalozzi, B. and Caspar, C. and Ruhstaller, T. and Roth, A. and Kappeler, A. and Dietrich, D. and Lanz, D. and Mingrone, W. and Swiss, Group for Clinical Cancer Research and Bern, and Switzerland, . (2008) Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer : a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK. Annals of oncology, Vol. 19, H. 7. S. 1288-1292.

Coates, Alan and Mouridsen, Henning and Thürlimann, Beat. (2008) Inappropriate ATAC on tamoxifen. The Lancet oncology, Vol. 9. S. 315-316.

Crivellari, Diana and Sun, Zhuoxin and Coates, Alan S. and Price, Karen N. and Thürlimann, Beat and Mouridsen, Henning and Mauriac, Louis and Forbes, John F. and Paridaens, Robert J. and Castiglione-Gertsch, Monica and Gelber, Richard D. and Colleoni, Marco and Láng, István and Del Mastro, Lucia and Gladieff, Laurence and Rabaglio, Manuela and Smith, Ian E. and Chirgwin, Jacquie H. and Goldhirsch, Aron. (2008) Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer : the BIG 1-98 trial. Journal of clinical oncology, Vol. 26. S. 1972-1979.

Greuter, S. and Schmid, F. and Ruhstaller, T. and Thuerlimann, B.. (2008) Bevacizumab-associated osteonecrosis of the jaw. Annals of oncology, Vol. 19, H. 12. S. 2091-2092.

Grimm, Birgit and Padberg, Barbara and Ruhstaller, Thomas and Fleisch, Felix and von Moos, Roger. (2008) Fatal herpes simplex virus hepatitis in a patient with esophageal cancer under radiochemotherapy. Onkologie, Vol. 31. S. 620-622.

Gruber, G. and Cole, B. F. and Castiglione-Gertsch, M. and Holmberg, S. B. and Lindtner, J. and Golouh, R. and Collins, J. and Crivellari, D. and Thürlimann, B. and Simoncini, E. and Fey, M. F. and Gelber, R. D. and Coates, A. S. and Price, K. N. and Goldhirsch, A. and Viale, G. and Gusterson, B. A.. (2008) Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer. Annals of oncology, Vol. 19, H. 8. S. 1393-1401.

Hess, V. and Glimelius, B. and Grawe, P. and Dietrich, D. and Bodoky, G. and Ruhstaller, T. and Bajetta, E. and Saletti, P. and Figer, A. and Scheithauer, W. and Herrmann, R.. (2008) CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial. The Lancet oncology, Vol. 9. S. 132-138.

Huober, Jens and Thürlimann, Beat. (2008) [Adjuvant endocrine therapy in breast cancer]. Therapeutische Umschau, Vol. 65. S. 193-200.

Koeberle, D. and Burkhard, R. and von Moos, R. and Winterhalder, R. and Hess, V. and Heitzmann, F. and Ruhstaller, T. and Terraciano, L. and Neuweiler, J. and Bieri, G. and Rust, C. and Toepfer, M.. (2008) Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer. British journal of cancer, Vol. 98, no. 7. S. 1204-1209.

Koeberle, D. and Saletti, P. and Borner, M. and Gerber, D. and Dietrich, D. and Caspar, C. B. and Mingrone, W. and Beretta, K. and Strasser, F. and Ruhstaller, T. and Mora, O. and Herrmann, R. and Swiss, Group for Clinical Cancer Research. (2008) Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine : a multicenter, phase II trial of the swiss group for clinical cancer research. Journal of clinical oncology, Vol. 26. S. 3702-3708.

Pestalozzi, Bernhard C. and Zahrieh, David and Mallon, Elizabeth and Gusterson, Barry A. and Price, Karen N. and Gelber, Richard D. and Holmberg, Stig B. and Lindtner, Jurij and Snyder, Raymond and Thürlimann, Beat and Murray, Elizabeth and Viale, Giuseppe and Castiglione-Gertsch, Monica and Coates, Alan S. and Goldhirsch, Aron. (2008) Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast : combined results of 15 International Breast Cancer Study Group clinical trials. Journal of clinical oncology, Vol. 26. S. 3006-3014.

Rasmussen, Birgitte B. and Regan, Meredith M. and Lykkesfeldt, Anne E. and Dell'Orto, Patrizia and Del Curto, Barbara and Henriksen, Katrine L. and Mastropasqua, Mauro G. and Price, Karen N. and Méry, Eliane and Lacroix-Triki, Magali and Braye, Stephen and Altermatt, Hans J. and Gelber, Richard D. and Castiglione-Gertsch, Monica and Goldhirsch, Aron and Gusterson, Barry A. and Thürlimann, Beat and Coates, Alan S. and Viale, Giuseppe. (2008) Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial. The Lancet oncology, Vol. 9. S. 23-28.

Regan, M. M. and Pagani, O. and Walley, B. and Torrisi, R. and Perez, E. A. and Francis, P. and Fleming, G. F. and Price, K. N. and Thürlimann, B. and Maibach, R. and Castiglione-Gertsch, M. and Coates, A. S. and Goldhirsch, A. and Gelber, R. D.. (2008) Premenopausal endocrine-responsive early breast cancer : who receives chemotherapy? Annals of oncology, Vol. 19, H. 7. S. 1231-1241.

Spirig, Christian and Thürlimann, Beat and Huober, Jens. (2008) [New treatment approaches in breast cancer]. Therapeutische Umschau, Vol. 65. S. 207-210.

Strasser, Florian and Demmer, Ruth and Böhme, Christel and Schmitz, Shu-Fang Hsu and Thuerlimann, Beat and Cerny, Thomas and Gillessen, Silke. (2008) Prevention of docetaxel- or paclitaxel-associated taste alterations in cancer patients with oral glutamine : a randomized, placebo-controlled, double-blind study. Oncologist, Vol. 13, H. 3. S. 337-346.

Viale, G. and Regan, M. M. and Maiorano, E. and Mastropasqua, M. G. and Golouh, R. and Perin, T. and Brown, R. W. and Kovács, A. and Pillay, K. and Öhlschlegel, C. and Braye, S. and Grigolato, P. and Rusca, T. and Gelber, R. D. and Castiglione-Gertsch, M. and Price, K. N. and Goldhirsch, A. and Gusterson, B. A. and Coates, A. S.. (2008) Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer : predictive value of centrally reviewed expression of estrogen and progesterone receptors, international breast cancer study group. Journal of clinical oncology, Vol. 9. S. 1404-1410.

Viale, Giuseppe and Giobbie-Hurder, Anita and Regan, Meredith M. and Coates, Alan S. and Mastropasqua, Mauro G. and Dell'Orto, Patrizia and Maiorano, Eugenio and MacGrogan, Gaëtan and Braye, Stephen G. and Ohlschlegel, Christian and Neven, Patrick and Orosz, Zsolt and Olszewski, Wojciech P. and Knox, Fiona and Thürlimann, Beat and Price, Karen N. and Castiglione-Gertsch, Monica and Gelber, Richard D. and Gusterson, Barry A. and Goldhirsch, Aron. (2008) Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer : results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole. Journal of clinical oncology, Vol. 26. S. 5569-5575.

von Moos, R. and Caspar, C. B. and Thürlimann, B. and Angst, R. and Inauen, R. and Greil, R. and Bergstrom, B. and Schmieding, K. and Pecherstorfer, M.. (2008) Renal safety profiles of ibandronate 6 mg infused over 15 and 60 min : a randomized, open-label study. Annals of oncology, Vol. 19, H. 7. S. 1266-1270.

von Moos, Roger and Thuerlimann, Beat J. K. and Aapro, Matti and Rayson, Daniel and Harrold, Karen and Sehouli, Jalid and Scotte, Florian and Lorusso, Domenica and Dummer, Reinhard and Lacouture, Mario E. and Lademann, Jürgen and Hauschild, Axel. (2008) Pegylated liposomal doxorubicin-associated hand-foot syndrome: recommendations of an international panel of experts. European journal of cancer, Vol. 44. S. 781-790.

2006

Wiederkehr, Oliver. Einfluss der Positronen-Emissions-Tomographie (PET) auf das Primärstaging und das weitere therapeutische Vorgehen bei Hochrisikopatientinnen mit Mammakarzinom. 2006, PhD Thesis, University of Basel, Faculty of Medicine.

This list was generated on Mon May 29 03:54:59 2017 CEST.